A Phase 2/3 interventional study of Doxycycline in Acne and Inflammation, sponsored by Shahid Beheshti University of Medical Sciences. Status unknown at 1 site in Iran. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-01-23.
Sponsored by Shahid Beheshti University of Medical Sciences · Phase 2/3, Interventional, and Treatment
The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.
750 studies on the registry are indexed under Acne Vulgaris; 89 are open to participants now.
This study's planned enrollment of 100 is above the median of 69 across 647 interventional studies indexed under Acne Vulgaris.
Browse Acne Vulgaris studies →Shahid Beheshti University of Medical Sciences is the lead sponsor of 229 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This study is status unknown, as verified in Jan 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Doxycycline
Shahid Beheshti University of Medical Sciences →